International trade · 13/12/1994Updated: 10/18/2026 · 1 min read
Patent Office Grants Interim Extension for Remeron
Summary
The U.S. Patent and Trademark Office has issued a certificate under the Patent Term Extension Act for a one-year extension of the term of U.S. Patent No. 4,062,848, which covers the human drug product Remeron.
Original source language: Federal Register — Department of CommerceOpen original release →